364 results
Page 10 of 19
8-K
EX-99.2
4rzwbgvb
10 Aug 12
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-99.1
3ab65af
3 Aug 12
Bristol-Myers Squibb Suspends Administration of Study Drug in Clinical Trial of Investigational NS5B Nucleotide for the Treatment of Hepatitis C
12:00am
8-K
EX-99.1
rpz3 ncfdemcr
25 Jul 12
Planned Acquisition of Amylin Expected to Add Two Marketed GLP-1 Agonists to Our Diabetes Franchise and Our Alliance with AstraZeneca
12:00am
8-K
EX-99.1
l1lzy6w ssv6bi
3 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
9y2pns9 o9a
26 Apr 12
Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones
12:00am
8-K
EX-99.1
ww1eru3mueqs
26 Jan 12
Net Sales Rise 7% to $5.5 Billion in Fourth Quarter
12:00am
8-K
EX-99.1
vkriqdcq
24 Jan 12
Bristol-Myers Squibb Names Gerald L. Storch to Board of Directors
12:00am
SC TO-T
EX-99
7qmvmyn9w5z6b0 qb
13 Jan 12
Third party tender offer statement
12:00am
8-K
EX-99.1
5mqobuqg02umga6so0
9 Jan 12
Bristol-Myers Squibb to Acquire Inhibitex
12:00am
8-K
EX-99.1
tthfp
27 Oct 11
Bristol-Myers Squibb Delivers Strong Third Quarter with Important Clinical Data, Solid Operating Results and Continued Focus on Business Development
12:00am
8-K
EX-99.1
6tyjo
21 Oct 11
Bristol-Myers Squibb Announces Changes in Senior Management Team
12:00am
8-K
EX-99.1
7kj0r339uiysrr67rlh
28 Jul 11
Important Clinical Data and Strong Financial Results
12:00am
8-K
EX-99.1
x1kd51njf7t24ynmerv3
28 Apr 11
Key R&D Milestones and Strong Financials
12:00am